ID   TGFA_RAT                Reviewed;         159 AA.
AC   P01134; Q63749;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   02-OCT-2024, entry version 176.
DE   RecName: Full=Protransforming growth factor alpha;
DE   Contains:
DE     RecName: Full=Transforming growth factor alpha;
DE              Short=TGF-alpha;
DE     AltName: Full=EGF-like TGF;
DE              Short=ETGF;
DE     AltName: Full=TGF type 1;
DE   Flags: Precursor;
GN   Name=Tgfa;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3855503; DOI=10.1038/313489a0;
RA   Lee D.C., Rose T.M., Webb N.R., Todaro G.J.;
RT   "Cloning and sequence analysis of a cDNA for rat transforming growth
RT   factor-alpha.";
RL   Nature 313:489-491(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=2325647; DOI=10.1128/mcb.10.5.2111-2121.1990;
RA   Blasband A.J., Rogers K.T., Chen X., Azizkhan J.C., Lee D.C.;
RT   "Characterization of the rat transforming growth factor alpha gene and
RT   identification of promoter sequences.";
RL   Mol. Cell. Biol. 10:2111-2121(1990).
RN   [3]
RP   PROTEIN SEQUENCE OF 39-88.
RX   PubMed=6320373; DOI=10.1126/science.6320373;
RA   Marquardt H., Hunkapiller M.W., Hood L.E., Todaro G.J.;
RT   "Rat transforming growth factor type 1: structure and relation to epidermal
RT   growth factor.";
RL   Science 223:1079-1082(1984).
RN   [4]
RP   PROTEIN SEQUENCE OF 39-67.
RX   PubMed=6605968; DOI=10.1016/s0021-9258(17)43958-5;
RA   Massague J.;
RT   "Epidermal growth factor-like transforming growth factor. I. Isolation,
RT   chemical characterization, and potentiation by other transforming factors
RT   from feline sarcoma virus-transformed rat cells.";
RL   J. Biol. Chem. 258:13606-13613(1983).
CC   -!- FUNCTION: TGF alpha is a mitogenic polypeptide that is able to bind to
CC       the EGF receptor/EGFR and to act synergistically with TGF beta to
CC       promote anchorage-independent cell proliferation in soft agar.
CC   -!- SUBUNIT: Interacts with the PDZ domains of MAGI3, SDCBP and SNTA1. The
CC       interaction with SDCBP, is required for the targeting to the cell
CC       surface. In the endoplasmic reticulum, in its immature form (i.e. with
CC       a prosegment and lacking full N-glycosylation), interacts with CNIH. In
CC       the Golgi apparatus, may form a complex with CNIH and GORASP2.
CC       Interacts (via cytoplasmic C-terminal domain) with NKD2 (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P01134; Q9H190: SDCBP2; Xeno; NbExp=6; IntAct=EBI-16418721, EBI-742426;
CC   -!- SUBCELLULAR LOCATION: [Transforming growth factor alpha]: Secreted,
CC       extracellular space.
CC   -!- SUBCELLULAR LOCATION: [Protransforming growth factor alpha]: Cell
CC       membrane; Single-pass type I membrane protein.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X02004; CAA26036.1; -; mRNA.
DR   EMBL; M31075; AAA42234.1; -; Genomic_DNA.
DR   EMBL; M31076; AAA42233.1; -; mRNA.
DR   PIR; A93356; WFRT1.
DR   PIR; I57497; I57497.
DR   RefSeq; NP_036803.1; NM_012671.2.
DR   AlphaFoldDB; P01134; -.
DR   SMR; P01134; -.
DR   IntAct; P01134; 2.
DR   STRING; 10116.ENSRNOP00000054248; -.
DR   GlyCosmos; P01134; 1 site, No reported glycans.
DR   GlyGen; P01134; 1 site.
DR   PaxDb; 10116-ENSRNOP00000054248; -.
DR   GeneID; 24827; -.
DR   KEGG; rno:24827; -.
DR   UCSC; RGD:3849; rat.
DR   AGR; RGD:3849; -.
DR   CTD; 7039; -.
DR   RGD; 3849; Tgfa.
DR   VEuPathDB; HostDB:ENSRNOG00000016182; -.
DR   eggNOG; ENOG502RYAF; Eukaryota.
DR   HOGENOM; CLU_109645_1_0_1; -.
DR   InParanoid; P01134; -.
DR   OrthoDB; 4264046at2759; -.
DR   PhylomeDB; P01134; -.
DR   TreeFam; TF332938; -.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-177929; Signaling by EGFR.
DR   Reactome; R-RNO-179812; GRB2 events in EGFR signaling.
DR   Reactome; R-RNO-180292; GAB1 signalosome.
DR   Reactome; R-RNO-180336; SHC1 events in EGFR signaling.
DR   Reactome; R-RNO-182971; EGFR downregulation.
DR   Reactome; R-RNO-204005; COPII-mediated vesicle transport.
DR   Reactome; R-RNO-212718; EGFR interacts with phospholipase C-gamma.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-5694530; Cargo concentration in the ER.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-RNO-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-RNO-9009391; Extra-nuclear estrogen signaling.
DR   PRO; PR:P01134; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000016182; Expressed in ovary and 15 other cell types or tissues.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; IDA:RGD.
DR   GO; GO:0008083; F:growth factor activity; ISS:HGNC-UCL.
DR   GO; GO:0048018; F:receptor ligand activity; ISO:RGD.
DR   GO; GO:0030297; F:transmembrane receptor protein tyrosine kinase activator activity; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISO:RGD.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; ISS:HGNC-UCL.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0038134; P:ERBB2-EGFR signaling pathway; ISO:RGD.
DR   GO; GO:0072574; P:hepatocyte proliferation; IDA:UniProtKB.
DR   GO; GO:0060749; P:mammary gland alveolus development; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:RGD.
DR   GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; ISS:HGNC-UCL.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISS:HGNC-UCL.
DR   GO; GO:0045840; P:positive regulation of mitotic nuclear division; IBA:GO_Central.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   Gene3D; 2.10.25.10; Laminin; 1.
DR   InterPro; IPR000742; EGF-like_dom.
DR   PANTHER; PTHR10740:SF1; PROTRANSFORMING GROWTH FACTOR ALPHA; 1.
DR   PANTHER; PTHR10740; TRANSFORMING GROWTH FACTOR ALPHA; 1.
DR   PRINTS; PR00009; EGFTGF.
DR   SUPFAM; SSF57196; EGF/Laminin; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Direct protein sequencing; Disulfide bond; EGF-like domain;
KW   Glycoprotein; Growth factor; Lipoprotein; Membrane; Mitogen; Palmitate;
KW   Reference proteome; Secreted; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..159
FT                   /note="Protransforming growth factor alpha"
FT                   /id="PRO_0000302748"
FT   PROPEP          24..38
FT                   /note="Removed in mature form"
FT                   /id="PRO_0000007764"
FT   CHAIN           39..88
FT                   /note="Transforming growth factor alpha"
FT                   /id="PRO_0000007765"
FT   PROPEP          89..159
FT                   /note="Removed in mature form"
FT                   /id="PRO_0000007766"
FT   TOPO_DOM        24..97
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        98..123
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        124..159
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          42..82
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   LIPID           152
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   LIPID           153
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        25
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        46..59
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        54..70
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        72..81
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   CONFLICT        28
FT                   /note="S -> P (in Ref. 1; CAA26036)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   159 AA;  16960 MW;  E9664EF04DFCF4D5 CRC64;
     MVPAAGQLAL LALGILVAVC QALENSTSPL SDSPVAAAVV SHFNKCPDSH TQYCFHGTCR
     FLVQEEKPAC VCHSGYVGVR CEHADLLAVV AASQKKQAIT ALVVVSIVAL AVLIITCVLI
     HCCQVRKHCE WCRALVCRHE KPSALLKGRT ACCHSETVV
//
